JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$761M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$735M |
| 3 |
Zimmer Biomet
ZBH
|
+$542M |
| 4 |
Amazon
AMZN
|
+$439M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$438M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.01B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.11B |
| 3 |
AABA
Altaba Inc
AABA
|
+$699M |
| 4 |
TJX Companies
TJX
|
+$682M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 22.01% |
| 2 | Financials | 14.82% |
| 3 | Technology | 12.49% |
| 4 | Healthcare | 9.61% |
| 5 | Consumer Discretionary | 8.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2451
Tanger
SKT
$4.03B
| $5.83M | ﹤0.01% |
220,039
+86,912
| +65% | +$2.15M |
2013 Q2
18 quarters
|
|
2452
Neogen
NEOG
$2.69B
| $5.79M | ﹤0.01% |
187,773
+183,858
| +4,696% | +$5.57M |
2015 Q3
9 quarters
|
|
2453
Vanda Pharmaceuticals
VNDA
$288M
| $5.77M | ﹤0.01% |
379,829
+320,491
| +540% | +$4.76M |
2015 Q4
8 quarters
|
|
|
DFS
2454
CALL
DELISTED
Discover Financial Services
DFS
| $5.77M | ﹤0.01% |
75,000
-141,100
| -65% | -$9.71M |
2017 Q3
1 quarter
|
|
|
TLRD
2455
PUT
DELISTED
Tailored Brands, Inc.
TLRD
| $5.76M | ﹤0.01% |
263,900
+156,800
| +146% | +$2.63M |
2017 Q3
1 quarter
|
|
2456
Algonquin Power & Utilities
AQN
$3.94B
| $5.76M | ﹤0.01% |
516,217
+99,182
| +24% | +$1.08M |
2017 Q1
3 quarters
|
|
2457
PUT
American Express
AXP
$203B
| $5.76M | ﹤0.01% |
58,000
+24,800
| +75% | +$2.36M |
2016 Q1
7 quarters
|
|
|
AGU
2458
CALL
DELISTED
Agrium
AGU
| $5.75M | ﹤0.01% |
+50,000
| New | +$5.42M |
2017 Q4
0 quarters
|
|
2459
QuidelOrtho
QDEL
$754M
| $5.75M | ﹤0.01% |
132,596
-88,437
| -40% | -$3.61M |
2015 Q3
9 quarters
|
|
|
NBIS
2460
Nebius Group N.V.
NBIS
$66.6B
| $5.75M | ﹤0.01% |
175,393
-113,208
| -39% | -$3.69M |
2013 Q4
16 quarters
|
|
|
HDV
2461
iShares Core High Dividend ETF
HDV
$14.7B
| $5.74M | ﹤0.01% |
318,100
-63,370
| -17% | -$1.11M |
2013 Q2
18 quarters
|
|
2462
Healthcare Services Group
HCSG
$1.43B
| $5.73M | ﹤0.01% |
108,701
+1,387
| +1% | +$72.7K |
2013 Q2
18 quarters
|
|
2463
Workiva
WK
$3.88B
| $5.71M | ﹤0.01% |
266,957
+128,382
| +93% | +$2.82M |
2016 Q4
4 quarters
|
|
2464
Adtran
ADTN
$581M
| $5.71M | ﹤0.01% |
294,797
-43,054
| -13% | -$956K |
2015 Q3
9 quarters
|
|
2465
Chord Energy
CHRD
$7.48B
| $5.7M | ﹤0.01% |
677,563
+675,870
| +39,921% | +$6.23M |
2016 Q4
4 quarters
|
|
|
DMC
2466
Del Monte Corp
DMC
$1.39B
| $5.69M | ﹤0.01% |
119,379
-45,243
| -27% | -$2.13M |
2013 Q2
18 quarters
|
|
|
ARNA
2467
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $5.69M | ﹤0.01% |
167,450
-144,868
| -46% | -$4.13M |
2016 Q4
4 quarters
|
|
|
LHCG
2468
DELISTED
LHC Group LLC
LHCG
| $5.69M | ﹤0.01% |
92,842
+92,124
| +12,831% | +$6.09M |
2016 Q2
6 quarters
|
|
2469
Wheaton Precious Metals
WPM
$61.5B
| $5.68M | ﹤0.01% |
256,486
+36,749
| +17% | +$766K |
2013 Q2
18 quarters
|
|
2470
iShares Europe ETF
IEV
$1.58B
| $5.67M | ﹤0.01% |
119,940
+104,351
| +669% | +$4.89M |
2015 Q4
8 quarters
|
|
|
AEGN
2471
DELISTED
Aegion Corp
AEGN
| $5.66M | ﹤0.01% |
222,690
+61,476
| +38% | +$1.54M |
2013 Q2
18 quarters
|
|
2472
Wave Life Sciences
WVE
$755M
| $5.66M | ﹤0.01% |
161,332
+43,232
| +37% | +$1.26M |
2017 Q3
1 quarter
|
|
|
LBRDK
2473
DELISTED
Liberty Broadband Class C
LBRDK
| $5.66M | ﹤0.01% |
66,461
+21,859
| +49% | +$1.95M |
2014 Q4
12 quarters
|
|
2474
PUT
Advanced Micro Devices
AMD
$1.04T
| $5.65M | ﹤0.01% |
550,000
+250,000
| +83% | +$2.92M |
2017 Q1
3 quarters
|
|
|
VG
2475
DELISTED
Vonage Holdings Corporation
VG
| $5.64M | ﹤0.01% |
554,384
+522,534
| +1,641% | +$4.77M |
2013 Q2
18 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2017 Portfolio in Review
As of Q4 2017, JP Morgan Chase held 5,783 positions worth $475B, up 4.7% from $453B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q4 2017 filing shows 812 new, 2,513 increased, 1,655 reduced and 342 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.01B.
By sector, the portfolio is most concentrated in Miscellaneous at 22% of assets, down from 24% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M.
- JP Morgan Chase added most to Johnson & Johnson in Q4 2017, an estimated $761M increase.
- JP Morgan Chase's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.01B.
- JP Morgan Chase fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $275M.
- JP Morgan Chase's ten largest holdings make up 18% of its $475B portfolio in Q4 2017.
- JP Morgan Chase opened 812 new positions and closed 342 in Q4 2017.
- JP Morgan Chase's portfolio value rose 4.7% quarter-over-quarter to $475B.
Based on JP Morgan Chase's 13F filing for Q4 2017, filed 13 Feb 2018.